Discussion about this post

User's avatar
WigWag's avatar

Another very important finding for multiple myeloma patients.

“New results from the two-part, double-randomized, German-speaking Myeloma Multicenter Group (GMMG)-HD7 phase 3 study show that Sarclisa (isatuximab) in combination with lenalidomide, bortezomib, and dexamethasone (RVd) during induction therapy in transplant-eligible, newly diagnosed multiple myeloma (NDMM) significantly prolonged progression-free survival (PFS) from first randomization, resulting in a statistically significant and clinically meaningful reduction in disease progression…”.

See,

https://www.globenewswire.com/news-release/2024/08/08/2926566/0/en/Press-Release-Sarclisa-induction-treatment-demonstrated-significantly-improved-progression-free-survival-in-patients-with-newly-diagnosed-multiple-myeloma-eligible-for-transplant.html

Expand full comment
jabster's avatar

I always love it when someone says "you will never walk again" and someone else says "Nonsense! We will make you so mobile that you can carry the Olympic torch or even get DISQUALIFIED from the Olympics for having too much of an advantage!"

As a matter of fact, we CAN rebuild him, and we DO have the technology. And it costs a lot less than six million dollars.

https://www.nytimes.com/2007/05/15/sports/othersports/15runner.html

Expand full comment
8 more comments...

No posts